ENVALITH
株式会社総医研ホールディングス logo

Soiken Holdings Inc.

2385Growth MarketServices

株式会社総医研ホールディングス logo
Soiken Holdings Inc.2385

Governance

The company has adopted the Audit & Supervisory Board system, comprising 7 directors (including 3 outside directors, one of whom resigned mid-term) and 3 Audit & Supervisory Board members (including 2 outside Audit & Supervisory Board members). All outside directors and outside Audit & Supervisory Board members have been registered as independent officers. Neither a nomination committee nor a compensation committee has been established.

Outside Director Ratio

33.3%

Nomination Committee

Not Established

Compensation Committee

Not Established

Risk Management

The company has established risk management regulations and built a structure centered on a risk management director appointed by the president. Risks related to overall business operations, including sustainability risks, are discussed at monthly board of directors meetings, and in the event of an emergency, a response headquarters headed by the president is set up to address the situation.

Shareholder Returns

The company's basic policy is a year-end dividend paid once a year, and for FY2026 (ending June 2026) it plans a dividend of ¥10 per share (double the ¥5 from the previous period). Share buybacks can be flexibly implemented via a resolution of the Board of Directors under provisions of the Articles of Incorporation.

Dividend Policy

The basic policy is to pay dividends after comprehensively considering business trends and the need to build up internal reserves in preparation for future R&D activities, with cash dividends paid once a year as a year-end dividend. Actual results for FY2025 (ended June 2025) were ¥5 per share (interim ¥0, year-end ¥5). The forecast for FY2026 (ending June 2026) is ¥10 per share (paid entirely as year-end dividend). The interim dividend is also expected to be ¥0 at the end of the second quarter of FY2026 (ending June 2026).

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

Based on the basic policy of "contributing to the realization of healthy and safe living for people by commercializing the results of medical science research," the company is working on human capital initiatives (promoting childcare leave uptake, improving paid leave utilization rates, encouraging comprehensive medical checkups) and environmental considerations (lightweighting packaging materials, reducing waste, reducing food loss). It discloses a male childcare leave uptake rate of 33.3% (target of 50% for FY2027 (ending June 2027)) and a paid leave utilization rate of 68.0% (target of 90% for FY2027 (ending June 2027)).

Last updated: September 24, 2025